Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Gliosarcoma 4 Glioma 4 Glioblastoma 4 Ganglioneuroblastoma 4 Pancreatic Neoplasms 3 Neuroblastoma 3 Vaginal Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Lung Neoplasms 2 Glioma, Subependymal 2 Ependymoma 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Astrocytoma 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thoracic Diseases 1

Interventions

parathyroid hormone-related peptide (1-36) 2 Cholecalciferol 2 upadacitinib 1 guizhi-shaoyao-zhimu decoction 1 Xylitol 1 Sodium Chloride 1 Parathyroid Hormone-Related Protein 1 Parathyroid Hormone 1 Epinephrine 1 Congresses as Topic 1 Clonidine 1 Adrenal Cortex Hormones 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Musculoskeletal Diseases × Congresses as Topic × Clear all

NCT03453905 2018-03-05

ZYCTFEA

Tel-Aviv Sourasky Medical Center

Phase NA Unknown

Disease, Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡